<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink">
  <front>
    <journal-meta />
    <article-meta>
      <title-group>
        <article-title>UBCS at IDPP: Predicting Patient Self-Assessment Score from Sensor Data using Machine Learning Algorithms</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <string-name>Chibuzor Chukwuemeka Okere</string-name>
          <xref ref-type="aff" rid="aff0">0</xref>
        </contrib>
        <contrib contrib-type="author">
          <string-name>Edwin Thuma</string-name>
          <xref ref-type="aff" rid="aff0">0</xref>
        </contrib>
        <contrib contrib-type="author">
          <string-name>Gontlafetse Mosweunyane</string-name>
          <xref ref-type="aff" rid="aff0">0</xref>
        </contrib>
        <aff id="aff0">
          <label>0</label>
          <institution>Department of Computer Science, University of Botswana</institution>
          ,
          <addr-line>Gaborone</addr-line>
          ,
          <country country="BW">Botswana</country>
        </aff>
      </contrib-group>
      <abstract>
        <p>In this paper, we explored various deep-learning techniques to develop machine learning models to perform Amyotrophic lateral sclerosis (ALS) prediction by predicting the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R) scores for patients' second auto evaluation. To perform the task, auto-encoders and multiple imputation techniques were used to handle missing values present within the dataset. After preprocessing the data, a Random Forest algorithm was used to perform feature selection after which 4 deep neural networks predictive models were developed. The four predictive models were developed using Multi-Layer Perceptron (MLP), Feed Forward Neural Network (FFNN), Recurrent Neural Network (RNN) and Long-short Term Memory (LSTM). However, the developed models performed poorly when compared to other models in the global ranking hence, 3 more algorithms (Random Forest, Gabbing Regressor and XGBoost algorithm) were used to improve the performance of the models and the developed XGBoost algorithm outperformed other models developed in this paper as it produces minimal MAE and RMSE values.</p>
      </abstract>
      <kwd-group>
        <kwd>eol&gt;Amyotrophic Lateral Sclerosis (ALS)</kwd>
        <kwd>ALSFRS-R</kwd>
        <kwd>Autoencoders</kwd>
        <kwd>LSTM</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="sec-1">
      <title>1. Introduction</title>
      <p>
        Amyotrophic lateral sclerosis (ALS) is a motor neuron disease that usually afects the nerve and spinal
cord of an adult. Today, ALS is seen as a multisystem neurodegenerative disorder, a progressive
neurodegenerative disease of adulthood caused by the loss of spinal, bulbar, and cortical motor neurons
which can cause voluntary muscles within the human body to paralyse. [
        <xref ref-type="bibr" rid="ref1">1</xref>
        ].ALS disease typically
consists of focus muscle weakness in adults from the onset. These weaknesses progress as the condition
of the disease increases. This weakness usually starts in the limb muscles which is usually greater in
the distal muscles when compared to the proximal muscles [
        <xref ref-type="bibr" rid="ref2">2</xref>
        ]. Currently, there is no specific cure
for the disease as its condition varies from patient to patient [
        <xref ref-type="bibr" rid="ref3">3</xref>
        ]. In the early ’70s and ’80s, several
eforts were put in by medical practitioners to develop a scale system that could be used to measure
the progression of ALS in patients. These early clinical trials started with the development of a scale
described by Norris in 1974 and another a decade later by Appel scale in 1984 [
        <xref ref-type="bibr" rid="ref4">4</xref>
        ]. These tools, however,
were time-consuming when used hence, in the ‘90s a much-improved tool called the ALS functional
rating scale (ALSFRS) was developed [
        <xref ref-type="bibr" rid="ref5">5</xref>
        ]. The ALS functional rating scale was designed to respond to 10
questions associated with the bulbar function, respiratory function, and upper and lower limb function
of the human body [
        <xref ref-type="bibr" rid="ref6">6</xref>
        ]. For each question, a grade scale between 0 to 4 was used as 0 stands for the
worst condition while 4 stands for the normal condition. A few years later, the original ALSFRS was
improved and revised to allow the inclusion of the respiratory function of the human body as it is a very
significant factor to be evaluated in ALS patients. The new improved scale was called ALSFRS-Revised.
This new revised scale consists of 12 questions i.e. an addition of 2 more questions to the initial 10 used
by ALSFRS. A healthy patient is expected to achieve a total of 48 points when this scaling system is used
to evaluate the progression of ALS while the lowest score to be achieved is 0 [
        <xref ref-type="bibr" rid="ref7">7</xref>
        ]. This scaling system is
relatively fast when compared to other evaluation techniques as it can be completed online or over the
telephone. To improve this method a way of measuring its progression in patients, a technique called
the Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS) was developed [
        <xref ref-type="bibr" rid="ref3 ref5 ref8">3, 8, 5</xref>
        ]. Recently, a
revised version of the ALSFRS called Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised
(ALSFRS-R) was developed providing a more specific evaluation of the physical functionalities of the
patient’s well-being [
        <xref ref-type="bibr" rid="ref9">9</xref>
        ]. However, manually collecting the ALSFRS-R values is subjective and relies
on self-reported data, making it prone to variability and bias which can afect its accuracy [
        <xref ref-type="bibr" rid="ref1">1</xref>
        ]. In
recent years, machine learning algorithms have been utilised in the field of ALS prediction to examine
the progression of ALS disease through prediction of the ALSFRS-R scores enabling the tracking of
ALS progression [
        <xref ref-type="bibr" rid="ref3">3</xref>
        ]. Researchers and medical practitioners utilise machine learning algorithms in
conjunction with several ALSFRS-R data, demographic and laboratory results to perform prediction of
ALS progression in patients as these algorithms are capable of learning from previous patient records and
making future predictions without explicitly being programmed [
        <xref ref-type="bibr" rid="ref1 ref10 ref3">3, 1, 10</xref>
        ]. The commonly used machine
learning algorithms are grouped into supervised and unsupervised learning algorithms. Supervised
learning algorithms are developed utilising labelled data of patient health conditions using various
methods such as classification, regression and deep learning [
        <xref ref-type="bibr" rid="ref1">1</xref>
        ]. Unsupervised learning on the other
hand utilises methods such as clustering and association on unlabeled patient data to examine ALS
progression [11]. Commonly used machine learning algorithms for ALS prediction Include random
forest, clustering algorithms, deep neural networks, and ensemble algorithms among others [
        <xref ref-type="bibr" rid="ref1 ref10 ref6">1, 10, 11, 6</xref>
        ].
These algorithms have been utilised to predict ALSFRS scores, and severity of ALS in patients and
perform grouping of patients based on the progression of their ALS disease. Despite the eficiency
machine-learning algorithms have brought to ALS prediction, its performance has been influenced by the
high level of heterogeneity and diferent symptoms that exist among patients making the development
of reliable, robust, and generalised machine-learning algorithms problematic. The need to develop
more robust, generalised, and reliable machine learning predictive models for ALS prediction prompted
the conduction of this research. Hence towards addressing this challenge, the IDPP CLEF 2024 Task 2:
Predicting Patient Self-Assessment Score using Sensor Data, encourages the development of reliable
machine learning predictive models for ALS prediction. In this work, we investigated the use of deep
neural networks in the prediction of ALSFRS-R. In particular, we developed a deep neural network
predictive model for predicting ALSFRS-R self-assessment scores of patients’ second auto-evaluation by
utilising sensor data collected via a mobile application. The paper is organised as follows: Section 2
presents related works done by several authors on ALS prediction; Section 3 explains the methodology
we used; Section 4 explains the setup of our experiment; Section 5 presents our results and discussions
on the findings made; Section 6 presents our conclusions based on these findings and possible areas for
future work.
      </p>
    </sec>
    <sec id="sec-2">
      <title>2. Related works on ALS prediction using Machine Learning</title>
      <p>
        Utilising machine learning algorithms for ALS prediction has come into the limelight in recent years.
Several authors have relied on the powerful ability of machine learning algorithms to develop predictive
models for ALS predictions. Convolutional deep neural networks have been utilised by [
        <xref ref-type="bibr" rid="ref1">1</xref>
        ]to develop
an ALS predictive model by examining the speech functionality of patients. The developed model
by this author produced an AUC score of 86%. Also, another author relies on the strength of deep
neural networks by comparing them with traditional algorithms for predicting ALS progression in
patients. The Algorithms utilised by the authors were Convolutional Neural Networks (CNN), Feed
Forward Neural network (FFNN), Recurrent Neural Networks (RNN), Feed Forward Neural network +
Convolutional Neural networks (FFNN+CNN), Bidirectional and Auto-Regressive Transformer (BART),
and Random Forest (RF). To examine the performance of the developed models the authors utilised Root
Mean Squared Deviation (RMSD) and Pearson Correlation CCoeficient (PCC) for which FFNN+CNN
outperformed other models as it produced the least RMSD and PCC scores of 0.543 and 0.415 respectively.
Another author proposed a machine-learning algorithm for examining 1-year survival rate and disease
progression of ALS patients by utilising a Light Gradient Boosting Machine (LGBM) and Uniform
Manifold Approximation Projection (UMAP) [11]. The developed LGBM model has an RMSE of 2.86
and an R-squared value of 0.79 while the developed U MAP algorithm has a prediction quality of 92.75%.
Another study conducted by Papaiz et al. [
        <xref ref-type="bibr" rid="ref6">6</xref>
        ] introduced an Ensemble algorithm alongside 6 traditional
algorithms to predict short survival rate of ALS patients using the PRO-ACT dataset. The models
utilised by the authors were K-nearest Neighbour, Decision tree, random forest, support vector machine,
Naive Bayes and Neural networks. Upon development and evaluation of the developed models, neural
networks produced the optimal performance with an accuracy score of 88%. Despite the high accuracy
of their models, the authors highlighted the need to consider using advanced algorithms called black
boxes (Neural networks) as these algorithms would perform better in the development of more robust
algorithms when compared to traditional algorithms. The authors also highlighted the need for efective
missing value and data imbalance handling as these issues have an impact on developed models. Overall,
Gordon et. al. [
        <xref ref-type="bibr" rid="ref3">3</xref>
        ] highlighted that utilising these machine learning techniques and algorithms can help
reduce human errors and facilitating the treatment process. However, there is still a need to develop a
more reliable machine-learning predictive model for ALS prediction.
      </p>
    </sec>
    <sec id="sec-3">
      <title>3. Methodology</title>
      <sec id="sec-3-1">
        <title>3.1. Dataset</title>
        <p>To perform prediction of the ALSFRS-R patient self-assessment score, we utilised various deep learning
algorithms to develop predictive models. Below is a description of the dataset alongside approaches
utilised during model development:
The dataset provided for the IDPP CLEF 2024 Task 2 contains records of 52 patients [12, 13]. The dataset
was grouped into 3 distinct datasets containing static data, sensor data and ALSFRS scores data of these
52 patients. Overall, the dataset for these 52 patients contains 301 self-assessed ALSFRS-R and 13946
days of sensor data. However, there are a lot of missing values within the dataset especially the sensor
data due to patients failing to provide information on some days. For analysis purposes, we combined
the 3 datasets using patient ID and days of diagnosis. Upon combining, the formed data set consists of
110 attributes and 7061 patient records.</p>
      </sec>
      <sec id="sec-3-2">
        <title>3.2. Data preprocessing</title>
        <p>
          One significant step we carried out was the preprocessing of data. In particular, we combined the
three (3) diferent datasets for analysis. In addition, we performed missing values handling, feature
transformation, feature selection, and feature scaling. To combine the 3 provided datasets by the
IDPP CLEF 2024 Task 2 [12], we utilised the pandas library. Firstly, we combined the ALSFRS-R Data
alongside the patient static data using patient ID which is a common attribute between the two datasets.
This led to the formation of a single dataset containing both static data and ALSFRS-R data of the 52
examined patients. To combine the newly formed dataset with the sensor dataset, patient ID and days
of diagnosis were utilised as these columns were common columns between the two datasets. The
developed dataset has 7073 rows and 110 columns. However, many missing values were present in the
developed dataset. Values present within the dataset that do not have corresponding key values (same
patient ID and days of diagnosis) were dropped from the dataset hence the final developed dataset
contained 299 rows and 110 columns. To handle missing values still present within the well-matched
dataset, we utilised two techniques using autoencoders and multiple imputation techniques as provided
in the mice forest library [14]. These two methods are more powerful as compared to traditional mean
and median way of handling missing data. This is because the said traditional methods are prone to
outliers and don’t check for relationship from other variables present in the dataset. Auto encoders
and Multiple Imputation check for relationship between variables thereby reducing outliers and noise.
The main reason for combining both methods is because auto encoders can be biased while multiple
imputation has computational complexity. So the idea is to use auto encoders to minimize missing
values and then multiple imputation handles the bias therefore giving a robust, scalable and flexible
technique of handling missing values. So basically, these two methods complement each other in
handling missing values. For feature transformation, categorical data present within the dataset were
converted to categories using a label encoder. To select features, a Random forest algorithm was used
to sort features based on their importance [
          <xref ref-type="bibr" rid="ref1">1</xref>
          ]. The selected features that provide optimum performance
upon the development of models were 10 in total depicted in Figure 1. Upon selecting features, we
performed scaling of the selected features using MinMaxscaler and StandardScaler libraries provided by
the sklearn library for normalisation and standardisation of data.
        </p>
      </sec>
      <sec id="sec-3-3">
        <title>3.3. Algorithm Utilised</title>
        <p>
          For our investigation, 4 deep neural networks were used for model development. These neural networks
were multi-layer perception (MLP), feed-forward neural networks (FFNN), recurrent neural network
(RNN) and Long-short Term Memory Neural networks (LSTM) [
          <xref ref-type="bibr" rid="ref1">1</xref>
          ]. The structure of a neural network
algorithm is depicted in Figure 2. Deep neural works consist of input layers, hidden layers and output
layers. For a prediction to be done, input data are fed to the input layer which passes it to the hidden
layer through the weights of the neurons [15]. This hidden layer does the majority of the work within
the deep neural network architecture and then finally passes its predictions to the output layer [
          <xref ref-type="bibr" rid="ref1">1</xref>
          ]. The
MLP and LSTM are feed-forward algorithms while the RNN and LSTM are recurrent neural network
algorithms that work by propagating backwards to update weights of neural networks to reduce class
weight to reduce loss or error of a developed model [16]. All developed deep neural networks consist of
1 input layer containing neurons based on the number of selected features, 5 hidden layers (4 dense
layers and 1 dropout layer), and an output layer expected to produce 12 outputs. We utilised the relu
activation function for both input and output layers and the linear activation function of the output
layer as the task at hand is a regression problem.
        </p>
        <p>In this work, we used mean absolute error (MAE) and Root Mean Squared Error (RMSE) to evaluate
the performance of each developed model [18]. Evaluating the performance of a machine learning
model is crucial in machine learning as it tells how well a model is performing predictions [18]. MAE
are used to calculate the error of an algorithm as the evaluation technique can handle outliers resent
within a dataset RMSE however is sensitive to outliers and penalises errors more than RMSE due to
the squaring done when generating the mean squared error of an algorithm Root Mean Squared Error
(RMSE) and Mean Absolute Error (MAE) [19]. MAE and RMSE are calculated using equations 1 and 2
shown below:</p>
        <p>MAE = 1 ∑︁ ||</p>
        <p>=1
⎯</p>
        <p>RMSE = ⎷⎸⎸ 1 ∑=︁0 ||2
Where n = Total number of samples
i = each sample in the dataset
e = error of each instance</p>
      </sec>
    </sec>
    <sec id="sec-4">
      <title>4. Experimental Setup</title>
      <sec id="sec-4-1">
        <title>4.1. Repository Organization</title>
        <p>The repository is organized into 4 sections containing the code, scores, submissions, resources and report.
The code folder contains all Jupyter files developed during model development, the submission folder
contains all the runs we developed, the scores folder contains all the scores of developed models and the
resource folder holds other developed files during model development such as exported best-performing
models.</p>
      </sec>
      <sec id="sec-4-2">
        <title>4.2. Tools used</title>
        <sec id="sec-4-2-1">
          <title>Tools utilised for the experiment include: 1. Toshiba Satellite c850 Laptop (core i5 8gig Ram 2.5 GHZ) 2. Jupyter Notebook 3. Libraries used (pandas, sklearn, Tensorflow, mice library, matplotlib, numpy and pickle)</title>
        </sec>
      </sec>
      <sec id="sec-4-3">
        <title>4.3. Training and Validation dataset</title>
        <sec id="sec-4-3-1">
          <title>We split our dataset into training and validation splits in the ratio of 90 to 10%</title>
        </sec>
      </sec>
      <sec id="sec-4-4">
        <title>4.4. Description of run</title>
        <p>For this experiment, 6 runs were developed based on feature selection. The runs are depicted in Table 1
below. Among the runs, run 1 which contains 10 features (age_at_diagnosis, bmi, weight, total_steps,
steps_12_pm-6_pm, step_6_am-12_pm, days, FVC, heart_rate_r2 and diagnostic_delay) outperformed
other runs hence it was picked for further improvement of the developed model.</p>
      </sec>
    </sec>
    <sec id="sec-5">
      <title>5. Results and Discussion</title>
      <p>Description
In this run, the top 10 features from the dataset were
selected using the random forest algorithm to develop the
deep learning models for ALSFRS-R prediction
In this run, the top 20 features from the dataset were
selected using the used random forest algorithm to develop
the deep learning models for ALSFRS-R prediction
In this run, the top 25 features from the dataset were
selected using the used random forest algorithm to develop
the deep learning models for ALSFRS-R prediction
In this run, the top 50 features from the dataset were
selected using the used random forest algorithm to develop
the deep learning models for ALSFRS-R prediction
In this run, the top 100 features from the dataset were
selected using the used random forest algorithm to develop
the deep learning models for ALSFRS-R prediction
In this run, all features in the dataset were selected using the
used random forest algorithm to develop the deep learning
models for ALSFRS-R prediction</p>
      <p>The results depicted in Table 2 show the global ranking of the IDPP CLEFF 2024 competition for Task
2 which focuses on developing a machine learning predictive model for ALSFRS-R value for the patient’s
second assessment. Our submissions (which occupy positions 25 to 29 and 31 denoted using Ubcs) were
ranked low among other submissions as they produced higher RMSE and MAE when compared to
models developed by other teams. These low performances by our developed models can be attributed
to the fact that deep neural networks are not being suitable for the task at hand as other algorithms.
In particular, ensemble algorithms used by other teams outperformed the deep neural networks. To
improve our developed model, we conducted further analysis by utilising 3 ensemble algorithms which
were Random Forest, Bagging Regressor, and XGBoost algorithm to improve our work. Ensemble
algorithms are a group of machine learning algorithms formed through the combination of diferent
learning models to produce a single model with better performance. Common types of ensemble
learning algorithms include Bagging algorithms, Extreme Gradient Boosting algorithms, Random forest,
Stacking algorithms [20]. The developed ensemble models gave improved performance similar to that
of highly ranked teams. Among the developed ensemble predictive models, It can be seen in Figure 3
and Table 3 that the XgBoost algorithm gave a higher performance on run 1 as it produced an MAE
value of 0.413889 and an RMSE value of 0.747217 indicating that ensemble algorithms have the potential
to outperform deep neural networks on the given task.</p>
    </sec>
    <sec id="sec-6">
      <title>6. Conclusion and Future work</title>
      <p>In this paper, deep neural networks were utilised to develop models for predicting ALSFRS-R
selfassessment scores for patients. Despite how powerful deep neural networks are, the results achieved in
this work showed that other algorithms such as ensemble algorithms have the potential to outperform
deep neural networks. This was seen as we attempted to improve the model and utilised ensemble
algorithms which produced better performance than the initially developed predictive models using
deep neural networks. The dataset size used during model training also plays a major role in the low
performance of the developed model. In future work, suficient data can be utilised for training to
improve the performance of the developed models. Also, hyper-parameter fine-tuning techniques such
as GridsearchCV alongside cross-validation techniques can be used on developed models to improve
performance.
[11] T. Anani, J.-F. Pradat-Peyre, F. Delbot, P.-F. Pradat, Machinelearning and feature selection methods
to predict 1-year survival and disease progression for amyotrophic lateral sclerosis (2024).
[12] G. Birolo, P. Bosoni, G. Faggioli, H. Aidos, R. Bergamaschi, P. Cavalla, A. Chiò, A. Dagliati,
M. de Carvalho, G. M. Di Nunzio, P. Fariselli, J. Manuel, G. Dominguez, M. Gromicho, A. Guazzo,
E. Longato, S. C. Madeira, U. Manera, S. Marchesin, L. Menotti, G. Silvello, E. Tavazzi, E. Tavazzi,
I. Trescato, M. Vettoretti, B. Di Camillo, N. Ferro, Overview of idpp@clef 2024: The intelligent
disease progression prediction challenge, in: Working Notes of the Conference and Labs of the
Evaluation Forum (CLEF 2024), Grenoble, France, September 9th to 12th, 2024, CEUR Workshop
Proceedings, CEUR-WS.org, 2024.
[13] G. Birolo, P. Bosoni, G. Faggioli, H. Aidos, R. Bergamaschi, P. Cavalla, A. Chiò, A. Dagliati,
M. de Carvalho, G. M. Di Nunzio, P. Fariselli, J. Manuel, G. Dominguez, M. Gromicho, A. Guazzo,
E. Longato, S. C. Madeira, U. Manera, S. Marchesin, L. Menotti, G. Silvello, E. Tavazzi, E. Tavazzi,
I. Trescato, M. Vettoretti, B. Di Camillo, N. Ferro, Intelligent Disease Progression Prediction:
Overview of iDPP@CLEF 2024, in: Experimental IR Meets Multilinguality, Multimodality, and
Interaction - 15th International Conference of the CLEF Association, CLEF 2024, Grenoble, France,
September 9-12, 2024, Proceedings, 2024.
[14] X. Dai, Evaluating the Performance of Diferent Multiple Imputation Methods When Imputing</p>
      <p>Missingness in Time-Series-Cross-Sectional Data, Ph.D. thesis, University of Washington, 2019.
[15] P. Sharma, S. K. Dinkar, D. Gupta, A novel hybrid deep learning method with cuckoo search
algorithm for classification of arrhythmia disease using ecg signals, Neural computing and
Applications 33 (2021) 13123–13143.
[16] P. Murugan, Feed forward and backward run in deep convolution neural network, arXiv preprint
arXiv:1711.03278 (2017).
[17] T. Babs, The mathematics of neural networks, Medium, July (2018).
[18] T. Chai, R. Draxler, A. Stein, Source term estimation using air concentration measurements and a
lagrangian dispersion model–experiments with pseudo and real cesium-137 observations from the
fukushima nuclear accident, Atmospheric Environment 106 (2015) 241–251.
[19] M. Padhma, A comprehensive introduction to evaluating regression models, Data Science</p>
      <p>Blogathon updated On October 31st (2023).
[20] A. Soni, K. P. Shankar, Bank loan default prediction using ensemble machine learning algorithm,
in: 2022 Second International Conference on Interdisciplinary Cyber Physical Systems (ICPS),
IEEE, 2022, pp. 170–175.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="ref1">
        <mixed-citation>
          [1]
          <string-name>
            <given-names>C.</given-names>
            <surname>Pancotti</surname>
          </string-name>
          , G. Birolo,
          <string-name>
            <given-names>C.</given-names>
            <surname>Rollo</surname>
          </string-name>
          ,
          <string-name>
            <given-names>T.</given-names>
            <surname>Sanavia</surname>
          </string-name>
          ,
          <string-name>
            <given-names>B. Di</given-names>
            <surname>Camillo</surname>
          </string-name>
          ,
          <string-name>
            <given-names>U.</given-names>
            <surname>Manera</surname>
          </string-name>
          ,
          <string-name>
            <given-names>A.</given-names>
            <surname>Chiò</surname>
          </string-name>
          ,
          <string-name>
            <given-names>P.</given-names>
            <surname>Fariselli</surname>
          </string-name>
          ,
          <article-title>Deep learning methods to predict amyotrophic lateral sclerosis disease progression</article-title>
          ,
          <source>Scientific reports 12</source>
          (
          <year>2022</year>
          )
          <fpage>13738</fpage>
          .
        </mixed-citation>
      </ref>
      <ref id="ref2">
        <mixed-citation>
          [2]
          <string-name>
            <given-names>P.</given-names>
            <surname>Masrori</surname>
          </string-name>
          ,
          <string-name>
            <surname>P. Van Damme</surname>
          </string-name>
          ,
          <article-title>Amyotrophic lateral sclerosis: A clinical review</article-title>
          ,
          <source>European journal of neurology 27</source>
          (
          <year>2020</year>
          )
          <fpage>1918</fpage>
          -
          <lpage>1929</lpage>
          .
        </mixed-citation>
      </ref>
      <ref id="ref3">
        <mixed-citation>
          [3]
          <string-name>
            <given-names>J.</given-names>
            <surname>Gordon</surname>
          </string-name>
          ,
          <string-name>
            <given-names>B.</given-names>
            <surname>Lerner</surname>
          </string-name>
          ,
          <article-title>Insights into amyotrophic lateral sclerosis from a machine learning perspective</article-title>
          ,
          <source>Journal of Clinical Medicine</source>
          <volume>8</volume>
          (
          <year>2019</year>
          )
          <fpage>1578</fpage>
          .
        </mixed-citation>
      </ref>
      <ref id="ref4">
        <mixed-citation>
          [4]
          <string-name>
            <given-names>S. B.</given-names>
            <surname>Rutkove</surname>
          </string-name>
          ,
          <article-title>Clinical measures of disease progression in amyotrophic lateral sclerosis</article-title>
          ,
          <source>Neurotherapeutics</source>
          <volume>12</volume>
          (
          <year>2015</year>
          )
          <fpage>384</fpage>
          -
          <lpage>393</lpage>
          .
        </mixed-citation>
      </ref>
      <ref id="ref5">
        <mixed-citation>
          [5]
          <string-name>
            <given-names>F. G.</given-names>
            <surname>Vieira</surname>
          </string-name>
          ,
          <string-name>
            <given-names>S.</given-names>
            <surname>Venugopalan</surname>
          </string-name>
          ,
          <string-name>
            <given-names>A. S.</given-names>
            <surname>Premasiri</surname>
          </string-name>
          ,
          <string-name>
            <given-names>M.</given-names>
            <surname>McNally</surname>
          </string-name>
          ,
          <string-name>
            <given-names>A.</given-names>
            <surname>Jansen</surname>
          </string-name>
          ,
          <string-name>
            <given-names>K.</given-names>
            <surname>McCloskey</surname>
          </string-name>
          ,
          <string-name>
            <given-names>M. P.</given-names>
            <surname>Brenner</surname>
          </string-name>
          ,
          <string-name>
            <surname>S. Perrin,</surname>
          </string-name>
          <article-title>A machine-learning based objective measure for als disease severity</article-title>
          ,
          <source>NPJ digital medicine 5</source>
          (
          <year>2022</year>
          )
          <fpage>45</fpage>
          .
        </mixed-citation>
      </ref>
      <ref id="ref6">
        <mixed-citation>
          [6]
          <string-name>
            <given-names>F.</given-names>
            <surname>Papaiz</surname>
          </string-name>
          ,
          <string-name>
            <given-names>M. E. T.</given-names>
            <surname>Dourado</surname>
          </string-name>
          <string-name>
            <given-names>Jr</given-names>
            , R. A.
            <surname>de Medeiros</surname>
          </string-name>
          <string-name>
            <surname>Valentim</surname>
          </string-name>
          ,
          <string-name>
            <given-names>R.</given-names>
            <surname>Pinto</surname>
          </string-name>
          ,
          <string-name>
            <surname>A. H. F. de Morais</surname>
            ,
            <given-names>J. P.</given-names>
          </string-name>
          <string-name>
            <surname>Arrais</surname>
          </string-name>
          ,
          <article-title>Ensemble-imbalance-based classification for amyotrophic lateral sclerosis prognostic prediction: Identifying short-survival patients at diagnosis</article-title>
          ,
          <source>BMC Medical Informatics and Decision Making</source>
          <volume>24</volume>
          (
          <year>2024</year>
          )
          <fpage>80</fpage>
          .
        </mixed-citation>
      </ref>
      <ref id="ref7">
        <mixed-citation>
          [7]
          <string-name>
            <given-names>B.</given-names>
            <surname>Ilse</surname>
          </string-name>
          ,
          <string-name>
            <given-names>T.</given-names>
            <surname>Prell</surname>
          </string-name>
          ,
          <string-name>
            <given-names>M.</given-names>
            <surname>Walther</surname>
          </string-name>
          ,
          <string-name>
            <given-names>V.</given-names>
            <surname>Hartung</surname>
          </string-name>
          ,
          <string-name>
            <given-names>S.</given-names>
            <surname>Penzlin</surname>
          </string-name>
          ,
          <string-name>
            <given-names>F.</given-names>
            <surname>Tietz</surname>
          </string-name>
          ,
          <string-name>
            <given-names>O.-W.</given-names>
            <surname>Witte</surname>
          </string-name>
          ,
          <string-name>
            <given-names>B.</given-names>
            <surname>Strauss</surname>
          </string-name>
          ,
          <string-name>
            <given-names>J.</given-names>
            <surname>Grosskreutz</surname>
          </string-name>
          ,
          <article-title>Relationships between disease severity, social support and health-related quality of life in patients with amyotrophic lateral sclerosis</article-title>
          ,
          <source>Social Indicators Research</source>
          <volume>120</volume>
          (
          <year>2015</year>
          )
          <fpage>871</fpage>
          -
          <lpage>882</lpage>
          .
        </mixed-citation>
      </ref>
      <ref id="ref8">
        <mixed-citation>
          [8]
          <string-name>
            <given-names>J. D.</given-names>
            <surname>Berry</surname>
          </string-name>
          ,
          <string-name>
            <given-names>S.</given-names>
            <surname>Paganoni</surname>
          </string-name>
          ,
          <string-name>
            <given-names>K.</given-names>
            <surname>Carlson</surname>
          </string-name>
          ,
          <string-name>
            <given-names>K.</given-names>
            <surname>Burke</surname>
          </string-name>
          ,
          <string-name>
            <given-names>H.</given-names>
            <surname>Weber</surname>
          </string-name>
          ,
          <string-name>
            <given-names>P.</given-names>
            <surname>Staples</surname>
          </string-name>
          ,
          <string-name>
            <given-names>J.</given-names>
            <surname>Salinas</surname>
          </string-name>
          ,
          <string-name>
            <given-names>J.</given-names>
            <surname>Chan</surname>
          </string-name>
          ,
          <string-name>
            <given-names>J. R.</given-names>
            <surname>Green</surname>
          </string-name>
          ,
          <string-name>
            <given-names>K.</given-names>
            <surname>Connaghan</surname>
          </string-name>
          , et al.,
          <article-title>Design and results of a smartphone-based digital phenotyping study to quantify als progression</article-title>
          ,
          <source>Annals of clinical and translational neurology 6</source>
          (
          <year>2019</year>
          )
          <fpage>873</fpage>
          -
          <lpage>881</lpage>
          .
        </mixed-citation>
      </ref>
      <ref id="ref9">
        <mixed-citation>
          [9]
          <string-name>
            <given-names>N.</given-names>
            <surname>Zhou</surname>
          </string-name>
          ,
          <string-name>
            <given-names>P.</given-names>
            <surname>Manser</surname>
          </string-name>
          ,
          <article-title>Does including machine learning predictions in als clinical trial analysis improve statistical power?</article-title>
          ,
          <source>Annals of Clinical and Translational Neurology</source>
          <volume>7</volume>
          (
          <year>2020</year>
          )
          <fpage>1756</fpage>
          -
          <lpage>1765</lpage>
          .
        </mixed-citation>
      </ref>
      <ref id="ref10">
        <mixed-citation>
          [10]
          <string-name>
            <given-names>H.</given-names>
            <surname>Turabieh</surname>
          </string-name>
          ,
          <string-name>
            <given-names>A. S.</given-names>
            <surname>Afshar</surname>
          </string-name>
          ,
          <string-name>
            <given-names>J.</given-names>
            <surname>Statland</surname>
          </string-name>
          ,
          <string-name>
            <given-names>X.</given-names>
            <surname>Song</surname>
          </string-name>
          ,
          <string-name>
            <given-names>T. P. R. O.-A.</given-names>
            <surname>ALS</surname>
          </string-name>
          , C. T. Consortium,
          <article-title>Towards a machine learning empowered prognostic model for predicting disease progression for amyotrophic lateral sclerosis</article-title>
          ,
          <source>in: AMIA Annual Symposium Proceedings</source>
          , volume
          <volume>2023</volume>
          , American Medical Informatics Association,
          <year>2023</year>
          , p.
          <fpage>718</fpage>
          .
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>